These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17547509)

  • 1. Vaccine strategies against human cytomegalovirus infection.
    Zhong J; Khanna R
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):449-59. PubMed ID: 17547509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus vaccine: time to look for alternative options.
    Khanna R; Diamond DJ
    Trends Mol Med; 2006 Jan; 12(1):26-33. PubMed ID: 16337831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.
    Heineman TC; Schleiss M; Bernstein DI; Spaete RR; Yan L; Duke G; Prichard M; Wang Z; Yan Q; Sharp MA; Klein N; Arvin AM; Kemble G
    J Infect Dis; 2006 May; 193(10):1350-60. PubMed ID: 16619181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee.
    Arvin AM; Fast P; Myers M; Plotkin S; Rabinovich R;
    Clin Infect Dis; 2004 Jul; 39(2):233-9. PubMed ID: 15307033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
    Lilja AE; Mason PW
    Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in cytomegalovirus vaccine development.
    Schleiss M
    Herpes; 2005 Dec; 12(3):66-75. PubMed ID: 16393522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress toward an elusive goal: current status of cytomegalovirus vaccines.
    Schleiss MR; Heineman TC
    Expert Rev Vaccines; 2005 Jun; 4(3):381-406. PubMed ID: 16026251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.
    Herr W; Plachter B
    Expert Rev Vaccines; 2009 Aug; 8(8):999-1021. PubMed ID: 19627184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the current status of cytomegalovirus vaccines.
    Sung H; Schleiss MR
    Expert Rev Vaccines; 2010 Nov; 9(11):1303-14. PubMed ID: 21087108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.
    Yue Y; Barry PA
    Adv Virus Res; 2008; 72():207-26. PubMed ID: 19081492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a novel vaccine against human cytomegalovirus based on a chimeric Ad5F35 adenovirus vector expressing the immunodominant antigenic domain 1 epitope.
    Zhao P; Ma D; Yan S; Shao N; Zhang J; Bi Z; Dai J; Ji M; Ji C
    Intervirology; 2009; 52(1):35-42. PubMed ID: 19372702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus.
    Zhong J; Rist M; Cooper L; Smith C; Khanna R
    PLoS One; 2008 Sep; 3(9):e3256. PubMed ID: 18806877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.
    Plachter B
    Med Microbiol Immunol; 2016 Dec; 205(6):537-547. PubMed ID: 27519596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.
    Fu TM; An Z; Wang D
    Vaccine; 2014 May; 32(22):2525-33. PubMed ID: 24681264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus Vaccines: Current Status and Future Prospects.
    Anderholm KM; Bierle CJ; Schleiss MR
    Drugs; 2016 Nov; 76(17):1625-1645. PubMed ID: 27882457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.
    Dasari V; Smith C; Khanna R
    Expert Rev Vaccines; 2013 Jun; 12(6):661-76. PubMed ID: 23750795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review.
    Vancíková Z; Dvorák P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):179-87. PubMed ID: 12476798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor.
    Grigoleit GU; Kapp M; Hebart H; Fick K; Beck R; Jahn G; Einsele H
    J Infect Dis; 2007 Sep; 196(5):699-704. PubMed ID: 17674311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern?
    Schleiss MR
    Rev Med Virol; 2006; 16(2):73-82. PubMed ID: 16287195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
    Gerna G; Lilleri D
    New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.